文献速递妇科

妇科恶性肿瘤早期死亡率的种族和民族差异

Racial and ethnic differences in early death among gynecologic malignancy.
PubMed 文献 · Am J Obstet Gynecol · 2024-03-07

基于美国监测、流行病学和最终结果项目2000至2020年461300例妇科恶性肿瘤患者,评估确诊后2个月内早期死亡的种族和民族差异。虽随时间改善,但组间差异仍显著。

要点

  • 输卵管卵巢癌早期死亡率最高(10.5%),其次为阴道癌(5.5%)、宫颈癌(2.9%)、子宫癌(2.5%)、外阴癌(2.4%)。
  • 非西班牙裔黑人输卵管卵巢癌患者早期死亡率最高(14.5%),亚裔最低(6.4%)。
  • 输卵管卵巢癌早期死亡率随时间下降:非西班牙裔黑人从17.4%降至11.8%,非西班牙裔白人从12.3%降至9.5%,但组间差异仅 modestly 缩小。

核心结论

  • 约5%的妇科恶性肿瘤患者在确诊后2个月内死亡,非西班牙裔黑人输卵管卵巢癌患者早期死亡率超过10%。
  • 尽管早期死亡率有所改善,但种族和民族组间差异仍然显著,需要进一步评估。

研究设计与样本

  • 查询美国国立癌症研究所监测、流行病学和最终结果项目,纳入2000年至2020年461300例妇科恶性肿瘤患者,包括子宫癌242709例、输卵管卵巢癌119989例、宫颈癌68768例、外阴癌22991例、阴道癌6843例。
  • 早期死亡定义为指示癌症诊断后2个月内的死亡事件,按种族和民族进行评估。

主要发现

  • 非西班牙裔黑人输卵管卵巢癌患者早期死亡率最高(14.5%);输卵管卵巢癌种族差异最大(亚裔6.4% vs 非西班牙裔黑人14.5%),其次为子宫癌(亚裔1.6% vs 非西班牙裔黑人4.9%)和宫颈癌(西班牙裔1.8% vs 非西班牙裔黑人3.8%)(均P<.001)。
  • 输卵管卵巢癌中,非西班牙裔黑人早期死亡率从17.4%降至11.8%(调整比值比0.67;95%置信区间0.53-0.85),非西班牙裔白人从12.3%降至9.5%(调整比值比0.77;95%置信区间0.71-0.85)。
  • 输卵管卵巢癌组间差异仅 modestly 缩小:2000-2002年非西班牙裔白人12.3% vs 非西班牙裔黑人17.4%(调整比值比0.54;95%置信区间0.45-0.65),2018-2020年9.5% vs 11.8%(调整比值比0.65;95%置信区间0.54-0.78)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Racial and ethnic differences in early death after cancer diagnosis have not been well studied in gynecologic malignancy. OBJECTIVE: This study aimed to assess population-level trends and characteristics of early death among patients with gynecologic malignancy based on race and ethnicity in the United States. STUDY DESIGN: The National Cancer Institute's Surveillance, Epidemiology, and End Results Program was queried to examine 461,300 patients with gynecologic malignancies from 2000 to 2020, including uterine (n=242,709), tubo-ovarian (n=119,989), cervical (n=68,768), vulvar (n=22,991), and vaginal (n=6843) cancers. Early death, defined as a mortality event within 2 months of the index cancer diagnosis, was evaluated per race and ethnicity. RESULTS: At the cohort level, early death occurred in 21,569 patients (4.7%), including 10.5%, 5.5%, 2.9%, 2.5%, and 2.4% for tubo-ovarian, vaginal, cervical, uterine, and vulvar cancers, respectively (P<.001). In a race- and ethnicity-specific analysis, non-Hispanic Black patients with tubo-ovarian cancer had the highest early death rate (14.5%). Early death racial and ethnic differences were the largest in tubo-ovarian cancer (6.4% for Asian vs 14.5% for non-Hispanic Black), followed by uterine (1.6% for Asian vs 4.9% for non-Hispanic Black) and cervical (1.8% for Hispanic vs 3.8% to non-Hispanic Black) cancers (all, P<.001). In tubo-ovarian cancer, the early death rate decreased over time by 33% in non-Hispanic Black patients from 17.4% to 11.8% (adjusted odds ratio, 0.67; 95% confidence interval, 0.53-0.85) and 23% in non-Hispanic White patients from 12.3% to 9.5% (adjusted odds ratio, 0.77; 95% confidence interval, 0.71-0.85), respectively. The early death between-group difference diminished only modestly (12.3% vs 17.4% for 2000-2002 [adjusted odds ratio for non-Hispanic White vs non-Hispanic Black, 0.54; 95% confidence interval, 0.45-0.65] and 9.5% vs 11.8% for 2018-2020 [adjusted odds ratio, 0.65; 95% confidence interval, 0.54-0.78]). CONCLUSION: Overall, approximately 5% of patients with gynecologic malignancy died within the first 2 months from cancer diagnosis, and the early death rate exceeded 10% in non-Hispanic Black individuals with tubo-ovarian cancer. Although improving early death rates is encouraging, the difference among racial and ethnic groups remains significant, calling for further evaluation.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lee MW, Vallejo A, Furey KB, et al. Racial and ethnic differences in early death among gynecologic malignancy. Am J Obstet Gynecol. 2024. PMID: 38460831. doi:10.1016/j.ajog.2024.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。